Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma

Cited by (1,066)

Items 601–700 of 1,066

1. Targeting energy metabolism in brain cancer: review and hypothesis
   Thomas N. Seyfried, Purna Mukherjee · 2005 · Nutrition & Metabolism
2. Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM
   Wiedemeyer, W. Ruprecht, Dunn, Ian F., Quayle, Steven N., Zhang, Jianhua, Chheda, Milan G., Dunn, Gavin P., Zhuang, Li, Rosenbluh, Joseph, Chen, Shujuan, Xiao, Yonghong et al. · 2010 · Proceedings of the National Academy of Sciences
3. Temozolomide for high grade glioma
   Michael G. Hart, Ruth Garside, G Rogers, Ken Stein, Robin Grant · 2013 · Cochrane Database of Systematic Reviews
4. Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical Model
   Christina Hao Wang, Jason K. Rockhill, Maciej M. Mrugała, Danielle L. Peacock, Albert Lai, Katy Jusenius, Joanna Marguerite Wardlaw, Timothy Francis Cloughesy, Alexander M. Spence, Russell C. Rockne et al. · 2009 · Cancer Research
5. EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise
   Manfred Westphal, Cécile L. Maire, Katrin Lamszus · 2017 · CNS Drugs
6. Glioma infiltration and extracellular matrix: key players and modulators
   Valéria Pereira Ferrer, Vivaldo Moura‐Neto, Rolf Mentlein · 2018 · Glia
7. Melatonin in Cancer Treatment: Current Knowledge and Future Opportunities
   Wamidh H. Talib, Ahmad Riyad Alsayed, Alaa Abuawad, Safa Daoud, Asma Ismail Mahmod · 2021 · Molecules
8. Neural stem cell delivery of an oncolytic adenovirus in newly diagnosed malignant glioma: a first-in-human, phase 1, dose-escalation trial
   Jawad Fares, Atique U. Ahmed, Ilya V. Ulasov, Adam M. Sonabend, Jason M. Miska, Catalina Lee-Chang, Irina V. Balyasnikova, James P. Chandler, Jana Portnow, Matthew C. Tate et al. · 2021 · The Lancet Oncology
9. Invadopodia: At the cutting edge of tumour invasion
   Stanley S. Stylli, Andrew Henry Kaye, Peter Lock · 2008 · Journal of Clinical Neuroscience
10. Incorporating diffusion- and perfusion-weighted MRI into a radiomics model improves diagnostic performance for pseudoprogression in glioblastoma patients
    Jung Youn Kim, Ji Eun Park, Youngheun Jo, Woo Hyun Shim, Soo Jung Nam, Jeong Hoon Kim, Roh‐Eul Yoo, Seung Hong Choi, Ho Sung Kim · 2018 · Neuro-Oncology
11. DNA methylation in glioblastoma: impact on gene expression and clinical outcome
    Amandine Etcheverry, Marc Aubry, Marie de Tayrac, Élodie Vauléon, Rachel Boniface, Frédérique Guénot, Stéphan Saïkali, Abderrahmane Hamlat, Laurent Riffaud, Philippe Meneï et al. · 2010 · BMC Genomics
12. Targeting metabolism with a ketogenic diet during the treatment of glioblastoma multiforme
    Colin Eamon Champ, Joshua David Palmer, Jeff S. Volek, Maria Werner‐Wasik, David William Andrews, James J. Evans, Jon Glass, Lyndon Kim, Wenyin Shi · 2014 · Journal of Neuro-Oncology
13. Replication-Dependent Radiosensitization of Human Glioma Cells by Inhibition of Poly(ADP-Ribose) Polymerase: Mechanisms and Therapeutic Potential
    Fiona A. Dungey, Dana A. Löser, Anthony J. Chalmers · 2008 · International Journal of Radiation Oncology*Biology*Physics
14. The cellular origin for malignant glioma and prospects for clinical advancements
    Hui Zong, Roel G.W. Verhaak, Peter Canoll · 2012 · Expert Review of Molecular Diagnostics
15. Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms
    Arnab Chakravarti, Michael G. Erkkinen, Ulf Nestler, Roger Stupp, Minesh P. Mehta, Ken Aldape, Mark R. Gilbert, Peter McL. Black, Jay S. Loeffler · 2006 · Clinical Cancer Research
16. Probabilistic Radiographic Atlas of Glioblastoma Phenotypes
    Benjamin M. Ellingson, Albert Lai, Robert J. Harris, Julia M. Selfridge, William H. Yong, K. Das, Whitney B. Pope, Phioanh Leia Nghiemphu, Harry V. Vinters, Linda M. Liau et al. · 2012 · American Journal of Neuroradiology
17. Phase II trial of pazopanib (GW786034), an oral multi-targeted angiogenesis inhibitor, for adults with recurrent glioblastoma (North American Brain Tumor Consortium Study 06-02)
    FABIO MASSAITI IWAMOTO, Kathleen R. Lamborn, H. Ian Robins, Minesh P. Mehta, Shannon Chang, Nicholas Arthur Butowski, Lisa Marie DeAngelis, Lauren E. Abrey, Weiting Zhang, Michael D. Prados et al. · 2010 · Neuro-Oncology
18. Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier
    Eric C. Leuthardt, Chong Duan, Michael J. Kim, Jian Li Campian, Albert H. Kim, Michelle M. Miller‐Thomas, Joshua S. Shimony, David Dinh Tran · 2016 · PLoS ONE
19. Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo
    Hugo Guerrero‐Cazares, Stephany Yi Tzeng, Noah P. Young, Ameer Abutaleb, Alfredo Quiñones‐Hinojosa, Jordan J. Green · 2014 · ACS Nano
20. NRG Oncology/RTOG1205: A Randomized Phase II Trial of Concurrent Bevacizumab and Reirradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
    Christina I. Tsien, Stephanie L. Pugh, Adam Paul Dicker, Jeffrey J. Raizer, Martha M. Matuszak, Enrico C. Lallana, Jiayi Huang, Özer Algan, Nimisha Deb, Lorraine Portelance et al. · 2022 · Journal of Clinical Oncology
21. The Telomerase Antagonist, Imetelstat, Efficiently Targets Glioblastoma Tumor-Initiating Cells Leading to Decreased Proliferation and Tumor Growth
    Calin O. Marian, Steve K. Cho, Brian M. Mcellin, Elizabeth Anne Maher, Kimmo J. Hatanpaa, Christopher J. Madden, Bruce Mickey, Woodring Erik Wright, Jerry W. Shay, Robert M. Bachoo · 2010 · Clinical Cancer Research
22. Systematic review of supportive care needs in patients with primary malignant brain tumors
    Elizabeth M Ford, Susan Catt, Anthony J. Chalmers, Lesley J. Fallowfield · 2012 · Neuro-Oncology
23. Pediatric Brain Tumors: Innovative Genomic Information Is Transforming the Diagnostic and Clinical Landscape
    Amar J. Gajjar, Daniel C. Bowers, Matthias A. Karajannis, Sarah E. S. Leary, Hendrik Witt, Nicholas G. Gottardo · 2015 · Journal of Clinical Oncology
24. Epithelial-to-mesenchymal(-like) transition as a relevant molecular event in malignant gliomas
    Ulf D. Kahlert, Guido Nikkhah, Jarek Maciaczyk · 2012 · Cancer Letters
25. Adult Lineage Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes
    S. A. Alcantara Llaguno, Zi-Lai Wang, Daochun Sun, Jian Chen, Jing Xu, Euiseok J. Kim, K. Hatanpaa, J. Raisanen, D. Burns, Jane E. Johnson et al. · 2015 · Cancer Cell
26. Radiomic subtyping improves disease stratification beyond key molecular, clinical, and standard imaging characteristics in patients with glioblastoma
    Philipp Kickingereder, Ulf Neuberger, David Bonekamp, Paula L. Piechotta, MICHAEL A. GOETZ, Antje Wick, Martin Sill, Annekathrin Kratz, Russell Taki Shinohara, David Jones et al. · 2017 · Neuro-Oncology
27. Drug delivery challenges and future of chemotherapeutic nanomedicine for glioblastoma treatment
    Lakshmi Pallavi Ganipineni, Fabienne Danhier, Véronique Préat A · 2018 · Journal of Controlled Release
28. Circadian Regulator CLOCK Recruits Immune-Suppressive Microglia into the GBM Tumor Microenvironment
    Peiwen Chen, Wen‐Hao Hsu, Andrew H. Chang, Zhi Tan, Zhengdao Lan, Ashley Z. Zhou, Denise J. Spring, Frederick F. Lang, Yanru Wang, Ronald Anthony DePinho · 2020 · Cancer Discovery
29. Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
    Sunayama, Jun, Matsuda, Ken-Ichiro, Sato, Atsushi, Tachibana, Ken, Suzuki, Kaori, Narita, Yoshitaka, Shibui, Soichiro, Sakurada, Kaori, Kayama, Takamasa, Tomiyama, Arata et al. · 2010 · Stem Cells
30. Recurrent Glioblastoma: From Molecular Landscape to New Treatment Perspectives
    Cristina Birzu, Pim J. French, Mario Caccese, Giulia Cerretti, Ahmed Idbaïh, Vittorina Zagonel, Giuseppe Lombardi · 2020 · Cancers
31. Radiographic patterns of relapse in glioblastoma
    Marc Charles Chamberlain · 2010 · Journal of Neuro-Oncology
32. Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma1
    Michael D. Prados, Kathleen R. Lamborn, Susan Marina Chang, Eric M. Burton, Nicholas Arthur Butowski, Mary K. Malec, Ami Kapadia, Jane E. Rabbitt, Margaretta S. Page, Ann Fedoroff et al. · 2006 · Neuro-Oncology
33. Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme
    Melissa Kerkhof, Janneke Dielemans, Melanie S. M. van Breemen, Hanneke Zwinkels, Robert Walchenbach, MARTIN J.B. TAPHOORN, Charles J. Vecht · 2013 · Neuro-Oncology
34. Tumor Heterogeneity in Glioblastomas: From Light Microscopy to Molecular Pathology
    Aline Paixão Becker, Blake E. Sells, S. Haque, Arnab Chakravarti · 2021 · Cancers
35. Engineering a Brain Cancer Chip for High-throughput Drug Screening
    Fan, Yantao, Nguyen, Duong Thanh, Akay, Yasemin, Xu, Feng, Akay, Metin · 2016 · Scientific Reports
36. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids
    Philip C. De Witt Hamer, Angela A.G. van Tilborg, Paul P. Eijk, Peter Sminia, Dirk Troost, Cornelis J.F. Van Noorden, Bauke Ylstra, Sieger Leenstra · 2007 · Oncogene
37. Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
    Leland Hu, Jennifer Mary Eschbacher, Joseph E. Heiserman, Amylou Constance Dueck, William R. Shapiro, S. Liu, John P. Karis, Kris A. Smith, Stephen William Coons, Peter Nakaji et al. · 2012 · Neuro-Oncology
38. Temozolomide-associated hypermutation in gliomas
    Serah Choi, Yao Yu, Matthew Grimmer, Michael Traut Wahl, Susan Marina Chang, J Costello · 2018 · Neuro-Oncology
39. Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria
    C. Mircea S. Tesileanu, Linda Dirven, Maarten M.J. Wijnenga, Johan A F Koekkoek, Arnaud J.P.E. Vincent, Hendrikus Jan Dubbink, Peggy N. Atmodimedjo, Johan M. Kros, Sjoerd G. van Duinen, Marion Smits et al. · 2019 · Neuro-Oncology
40. Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis
    Lina Marenco-Hillembrand, Olindi Wijesekera, Paola Suárez-Meade, David Michael Mampre, Christina Jackson, Jennifer Peterson, Daniel Michael Trifiletti, Julie E. Hammack, Kyle J. Ortiz, Elizabeth R. Lesser et al. · 2020 · Journal of Neuro-Oncology
41. PRMT5 inhibition disrupts splicing and stemness in glioblastoma
    Patty Sachamitr, Jolene Caifeng Ho, Felipe E. Ciamponi, Wail Ba-Alawi, Fiona J. Coutinho, Paul Guilhamon, Michelle M. Kushida, Florence M.G. Cavalli, Lilian Lee, Naghmeh Rastegar et al. · 2021 · Nature Communications
42. Current status and recent advances in reirradiation of glioblastoma
    Giuseppe Caracciolo Minniti, Maximilian Niyazi, Filippo Alongi, Pierina Navarria, Claus Belka · 2021 · Radiation Oncology
43. Time-resolved single-cell transcriptomics defines immune trajectories in glioblastoma
    Daniel S. Kirschenbaum, Ken Xie, Florian Ingelfinger, Yonatan Katzenelenbogen, Kathleen Abadie, Thomas Look, Fadi Sheban, Truong San Phan, Baoguo Li, Pascale Zwicky et al. · 2023 · Cell
44. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
    Ragnhild Helseth, Eirik Helseth, Tom Børge Johannesen, Carl Wilhelm Langberg, Knut Lote, Pål André Rønning, David Scheie, Anne Vik, Torstein Ragnar Meling · 2010 · Acta Neurologica Scandinavica
45. Symptoms and problems in the end-of-life phase of high-grade glioma patients
    Eefje M. Sizoo, Lauren Braam, Tjeerd J. Postma, H. Roeline W. Pasman, J.J. Heimans, Martin Klein, Jaap C. Reijneveld, MARTIN J.B. TAPHOORN · 2010 · Neuro-Oncology
46. The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme
    Richard Martin Bambury, Min Yuen Teo, D. Power, A. Yusuf, Susan L. Murray, Jodie Emma Battley, Catherine Drake, Pauline O’Dea, Niamh Bermingham, Catherine Keohane et al. · 2013 · Journal of Neuro-Oncology
47. Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme
    Shuichi Izumoto, Akihiro Tsuboi, Yoshitaka Oka, Tsuyoshi Suzuki, Tetsuo Hashiba, Naoki Kagawa, Naoya Hashimoto, Motohiko Maruno, Olga A. Elisseeva, Toshiaki Shirakata et al. · 2008 · Journal of neurosurgery
48. Inhibition of TGF- β 2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies
    Peter Hau, Piotr Jachimczak, Reimar Schlingensiepen, Frank J. Schulmeyer, Tanja Jauch, Andreas Steinbrecher, Alexander T. Brawanski, Martin Andreas Proescholdt, Jürgen R. Schlaier, Johanna Buchroithner et al. · 2007 · Oligonucleotides
49. New strategies to deliver anticancer drugs to brain tumors
    Valentino Laquintana, Adriana Trapani, Nunzio Denora, Fan Wang, James M. Gallo, Giuseppe Trapani · 2009 · Expert Opinion on Drug Delivery
50. Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
    Bret B. Friday, S. K. Anderson, Jeannie F. Buckner, C. Yu, Caterina Giannini, F. Geoffroy, John F. Schwerkoske, Miroslaw A. Mazurczak, Howard M. Gross, Eduardo R. Pajon et al. · 2011 · Neuro-Oncology
51. ATM Kinase Inhibition Preferentially Sensitizes p53-Mutant Glioma to Ionizing Radiation
    Laura Biddlestone-Thorpe, Muhammad Sajjad, Elizabeth Rosenberg, Jason M. Beckta, Nicholas C.K. Valerie, Mary E. Tokarz, Bret R. Adams, Alison F. Wagner, Ashraf A. Khalil, Donna Gilfor et al. · 2013 · Clinical Cancer Research
52. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway
    Hong Li, Lei Chen, Junjie Li, Qiang Zhou, Annie Huang, Wei‐Wen Liu, Ke Wang, Liang Gao, Songtao Qi, Yuntao Lu · 2018 · Journal of Hematology & Oncology
53. EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
    Bryan W. Day, Brett William Stringer, Fares Al‐Ejeh, Michael J. Ting, John Wilson, Kathleen S. Ensbey, Paul R. Jamieson, Zara C. Bruce, Yi Chieh Lim, Carolin Offenhäuser et al. · 2013 · Cancer Cell
54. A randomised, open label phase III trial with nimotuzumab, an anti-epidermal growth factor receptor monoclonal antibody in the treatment of newly diagnosed adult glioblastoma
    Manfred Westphal, Oliver Heese, Joachim Peter Steinbach, Oliver Schnell, Gabriele Schackert, Hubertus Maximilian Mehdorn, D. Schulz, Matthias Simon, Uwe S. Schlegel, Christian Senft et al. · 2015 · European Journal of Cancer
55. Comparative assessment of 5 methods (methylation‐specific polymerase chain reaction, methylight, pyrosequencing, methylation‐sensitive high‐resolution melting, and immunohistochemistry) to analyze O6‐methylguanine‐DNA‐methyltranferase in a series of 100 glioblastoma patients
    Véronique Quillien, Audrey Lavenu, Lucie Karayan, Catherine Carpentier, Marianne Labussière, Thierry Lesimple, Olivier Louis Chinot, Michel Wager, Jérôme Honnorat, Stéphan Saïkali et al. · 2012 · Cancer
56. Porous chitosan-hyaluronic acid scaffolds as a mimic of glioblastoma microenvironment ECM
    Stephen J. Florczyk, Kui Wang, Soumen Jana, David L. Wood, Samara K. Sytsma, Jonathan G. Sham, Forrest M. Kievit, Miqin Zhang · 2013 · Biomaterials
57. Current Applications of MRI-Guided Laser Interstitial Thermal Therapy in the Treatment of Brain Neoplasms and Epilepsy: A Radiologic and Neurosurgical Overview
    Rostislav Medvid, A. Ruiz, Ricardo J. Komotar, Jonathan Russell Jagid, Michael E. Ivan, R M Quencer, Mehul B. Desai · 2015 · American Journal of Neuroradiology
58. Convection-enhanced delivery in glioblastoma: a review of preclinical and clinical studies
    Arman Jahangiri, Aaron T. Chin, Patrick Michael Flanigan, Rebecca Chen, Krystof S. Bankiewicz, Manish Kumar Aghi · 2016 · Journal of neurosurgery
59. Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence
    Fletcher-Sananikone, Eliot, Kanji, Suman, Tomimatsu, Nozomi, Di Cristofaro, Luis Fernando Macedo, Kollipara, Rahul K., Saha, Debabrata, Floyd, John R., Sung, Patrick, Hromas, Robert, Burns, Terry C. et al. · 2021 · Cancer Research
60. The Bromodomain protein BRD4 controls HOTAIR, a long noncoding RNA essential for glioblastoma proliferation
    Chiara Pastori, Philipp Kapranov, Clara Penas, Veronica J. Peschansky, Claude‐Henry Volmar, Jann Nagina Sarkaria, Amadé Bregy, Ricardo J. Komotar, Georges St. Laurent, Nagi G. Ayad et al. · 2015 · Proceedings of the National Academy of Sciences
61. Managing thrombocytopenia associated with cancer chemotherapy.
    David J. Kuter · 2015 · PubMed
62. Survival comparison between glioblastoma multiforme and other incurable cancers
    Ben Tran, Mark Andrew Rosenthal · 2010 · Journal of Clinical Neuroscience
63. Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline
    Nimish A. Mohile, Hans J. Messersmith, Na Tosha Gatson, Andreas Felix Hottinger, Andrew Lassman, Jordan Morton, Douglas Ney, Phioanh Leia Nghiemphu, Adriana Olar, Jeffery Olson et al. · 2021 · Journal of Clinical Oncology
64. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma
    Nanna Lindberg, Marianne Kastemar, Tommie Olofsson, Anja Smits, Lene Uhrbom · 2009 · Oncogene
65. Changing incidence and improved survival of gliomas
    Vincent K.Y. Ho, Jaap C. Reijneveld, Roelien H. Enting, Henri Paul Bienfait, Pierre A. J. T. Robe, Brigitta G. Baumert, Otto J. Visser · 2014 · European Journal of Cancer
66. Parametric Response Map As an Imaging Biomarker to Distinguish Progression From Pseudoprogression in High-Grade Glioma
    Christina I. Tsien, Craig J. Galbán, Thomas L. Chenevert, Timothy D. Johnson, Daniel Allan Hamstra, Pia C. Sundgren, Larry Junck, Charles Raymond Meyer, Alnawaz Rehemtulla, Theodore Steven Lawrence et al. · 2010 · Journal of Clinical Oncology
67. Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy
    Friedrich-Wilhelm Kreth, Niklas Thon, Matthias Simon, Manfred Westphal, Gabriele Schackert, Guido Nikkhah, Bettina Hentschel, Guido Reifenberger, Torsten Pietsch, Michael Weller et al. · 2013 · Annals of Oncology
68. Current Trends in Cancer Nanotheranostics: Metallic, Polymeric, and Lipid-Based Systems
    Catarina Oliveira Silva, Jacinta O. Pinho, Joana Lopes, António José Almeida, Maria Manuela Gaspar, Catarina Pinto Reis · 2019 · Pharmaceutics
69. CAR T cells for brain tumors: Lessons learned and road ahead
    David Akhavan, Darya Alizadeh, Dongrui Wang, Michael R. Weist, Jennifer Kelly Shepphird, Christine E. Brown · 2019 · Immunological Reviews
70. CAR-Engineered NK Cells for the Treatment of Glioblastoma: Turning Innate Effectors Into Precision Tools for Cancer Immunotherapy
    Michael C. Burger, Congcong Zhang, Patrick N. Harter, Annette Romanski, Florian Straßheimer, Christian Senft, Torsten Tonn, Joachim Peter Steinbach, Winfried S. Wels · 2019 · Frontiers in Immunology
71. Metformin Inhibits Growth of Human Glioblastoma Cells and Enhances Therapeutic Response
    Julie Sesen, Perrine Dahan, Sarah Scotland, Estelle Saland, Van Thi Dang, Anthony Lemarié, Betty Tyler, Henry Brem, Christine Toulas, Elizabeth Cohen‐Jonathan Moyal et al. · 2015 · PLoS ONE
72. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods
    James M. Mountz, Rafay Ahmed, Matthew J. Oborski, Frank Scott Lieberman, Misun Hwang · 2014 · Cancer Management and Research
73. Does Valproic Acid or Levetiracetam Improve Survival in Glioblastoma? A Pooled Analysis of Prospective Clinical Trials in Newly Diagnosed Glioblastoma
    Caroline Hertler, Thierry Gorlia, Olivier Louis Chinot, Mark R. Gilbert, Burt Nabors, Wolfgang Wick, Stephanie L. Pugh, Monika E. Hegi, Timothy Francis Cloughesy, Patrick Roth et al. · 2016 · Journal of Clinical Oncology
74. The role of bevacizumab in the treatment of glioblastoma
    Roberto Jose Diaz, Sheikh C. Ali, Mehreen Gull Qadir, Macarena I. de la Fuente, Michael E. Ivan, Ricardo Jorge Komotar · 2017 · Journal of Neuro-Oncology
75. CD70, a novel target of CAR T-cell therapy for gliomas
    Linchun Jin, Haitao Ge, Yu Long, Changlin Yang, Yifan Emily Chang, Luyan Mu, Elias Joseph Sayour, Gabriel De Leon, Qiong J. Wang, James Chih‐Hsin Yang et al. · 2017 · Neuro-Oncology
76. Transferrin receptors-targeting nanocarriers for efficient targeted delivery and transcytosis of drugs into the brain tumors: a review of recent advancements and emerging trends
    Hira Choudhury, Manisha Pandey, Pei Xin Chin, Yee Lin Phang, Jeng Yuen Cheah, Shu Chien Ooi, Kit‐Kay Mak, Mallikarjuna Rao Pichika, Prashant Kesharwani, Zahid Hussain et al. · 2018 · Drug Delivery and Translational Research
77. Photodynamic therapy for solid tumors: A review of the literature
    Rebecca L. Yanovsky, Diana W. Bartenstein, Gary S. Rogers, Steven Jay Isakoff, Steven T. Chen · 2019 · Photodermatology Photoimmunology & Photomedicine
78. Surgery guided by 5-aminolevulinic fluorescence in glioblastoma: volumetric analysis of extent of resection in single-center experience
    Ricardo Díez Valle, Sonia Tejada Solís, Miguel Angel Idoate, M. R. Garcia de Eulate, Pablo Daniel Domínguez, Javier Aristu · 2010 · Journal of Neuro-Oncology
79. A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
    Brian Arthur Thiessen, Clinton F. Stewart, Ming‐Sound Tsao, Suzanne Kamel‐Reid, Paula S. Schaiquevich, Warren P. Mason, Jacob C. Easaw, Karl Bélanger, Peter A. Forsyth, L. McIntosh et al. · 2009 · Cancer Chemotherapy and Pharmacology
80. Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma
    Sheng Han, Yang Liu, Qingchang Li, Zhonghua Li, Haipei Hou, Anhua Wu · 2015 · BMC Cancer
81. Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
    Jonathan Balquiedra Lamano, Jason Balquidera Lamano, Yuping D. Li, Joseph D. DiDomenico, Winward Choy, Dorina Veliceasa, Daniel Eduardo Oyon, Shayan Fakurnejad, Leonel Ampie, Kartik Kesavabhotla et al. · 2019 · Clinical Cancer Research
82. Carbon dots supported single Fe atom nanozyme for drug-resistant glioblastoma therapy by activating autophagy-lysosome pathway
    Pir Muhammad, Sumaira Hanif, Jingyun Li, Anna Guller, Fawad Ur Rehman, Muhammad Ismail, Dongya Zhang, Xiyun Yan, Kelong Fan, Bingyang Shi · 2022 · Nano Today
83. Photodynamic therapy (PDT) for malignant brain tumors – Where do we stand?
    Brendan J. Quirk, Garth Brandal, Steven Donlon, Juan Carlos Vera, Thomas S. Mang, Andrew B. Foy, Sean M. Lew, Albert W. Girotti, Sachin Jogal, Peter S. LaViolette et al. · 2015 · Photodiagnosis and Photodynamic Therapy
84. MicroRNA-21 targets LRRFIP1 and contributes to VM-26 resistance in glioblastoma multiforme
    Yiming Li, Weiqing Li, Yongji Yang, Yicheng Lu, Cheng He, Guohan Hu, Huimin Liu, Juxiang Chen, Jin He, Hongyu Yu · 2009 · Brain Research
85. Correlation Between O6-Methylguanine-DNA Methyltransferase and Survival in Inoperable Newly Diagnosed Glioblastoma Patients Treated With Neoadjuvant Temozolomide
    Olivier Louis Chinot, Maryline Barrié, Stéphane Fuentes, Nathalie Eudes, Sophie Lancelot, Philippe Métellus, Xavier Muracciole, Diane Braguer, L’Houcine Ouafik, Pierre‐Marie Martin et al. · 2007 · Journal of Clinical Oncology
86. A reference collection of patient-derived cell line and xenograft models of proneural, classical and mesenchymal glioblastoma
    Brett William Stringer, Bryan W. Day, Rochelle C. J. D’Souza, Paul R. Jamieson, Kathleen S. Ensbey, Zara C. Bruce, Yi Chieh Lim, Kate Goasdoué, Carolin Offenhäuser, Seçkin Akgül et al. · 2019 · Scientific Reports
87. Postradiation Imaging Changes in the CNS: How can we Differentiate Between Treatment Effect and Disease Progression?
    Amanda J. Walker, Jake Ruzevick, Ashkan A. Malayeri, Daniele Rigamonti, Michael K. Lim, Kristin Janson Redmond, Lawrence Richard Kleinberg · 2014 · Future Oncology
88. Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age
    Yohan Lee, Adrienne C. Scheck, Timothy Francis Cloughesy, Albert Lai, Jun Dong, Haumith Khan-Farooqi, Linda M. Liau, Steve Horvath, Paul S. Mischel, Stanley F. Nelson · 2008 · BMC Medical Genomics
89. The Role of Autophagy in Cancer
    Naiara Santana-Codina, Joseph Douglas Mancias, Alec C. Kimmelman · 2017 · Annual Review of Cancer Biology
90. Interleukins in glioblastoma pathophysiology: implications for therapy
    YT Yeung, KL McDonald, Thomas Grewal, Lenka Munoz · 2012 · British Journal of Pharmacology
91. Brain tumor-targeted drug delivery strategies
    Xiaoli Wei, Xishan Chen, Ying Min Man, Weiyue Lu · 2014 · Acta Pharmaceutica Sinica B
92. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging
    Sylvia Drabycz, Gloria B. Roldán, Paula A. de Robles, Daniel H. Adler, John B. McIntyre, Anthony M. Magliocco, John Gregory Cairncross, Joseph Ross Mitchell · 2009 · NeuroImage
93. Engineered gadolinium-doped carbon dots for magnetic resonance imaging-guided radiotherapy of tumors
    Fengyi Du, Lirong Zhang, Li Zhang, Miaomiao Zhang, Aihua Gong, Youwen Tan, Jiawen Miao, Yuhua Gong, Mingzhong Sun, Huixiang Ju et al. · 2016 · Biomaterials
94. The biology and mathematical modelling of glioma invasion: a review
    Juan Carlos López Alfonso, Katrin Talkenberger, Michael Seifert, Barbara Klink, Andrea J. Hawkins-Daarud, Kristin R. Swanson, Haralampos Hatzikirou, Andreas Deutsch · 2017 · Journal of The Royal Society Interface
95. Methotrexate-Loaded Extracellular Vesicles Functionalized with Therapeutic and Targeted Peptides for the Treatment of Glioblastoma Multiforme
    Zhilan Ye, Tao Zhang, Wenshan He, Honglin Jin, Cuiwei Liu, Zhe Yang, Jinghua Ren · 2018 · ACS Applied Materials & Interfaces
96. Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiforme
    David A. Reardon, Burt Nabors, Roger Stupp, Tom Mikkelsen · 2008 · Expert Opinion on Investigational Drugs
97. Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study
    David A. Reardon, Annick Desjardins, James J. Vredenburgh, Sridharan Gururangan, John Howard Sampson, Sith Sathornsumetee, Roger E. McLendon, James E. Herndon, Jennifer E. Marcello, Julie A. Norfleet et al. · 2009 · British Journal of Cancer
98. Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom, Dale Randall Shepard, Manmeet Singh Ahluwalia, Cathy J. Brewer, Neeraj Agarwal, Glen H. J. Stevens, John H. Suh, Steven A. Toms, Michael A. Vogelbaum, Robert John Weil et al. · 2009 · Journal of Neuro-Oncology
99. Optimal role of temozolomide in the treatment of malignant gliomas
    Roger Stupp, Martin J. van den Bent, Monika E. Hegi · 2005 · Current Neurology and Neuroscience Reports
100. Multiple resections for patients with glioblastoma: prolonging survival
     Kaisorn Lee Chaichana, Patricia L. Zadnik, JON D. WEINGART, Alessandro Olivi, Gary L. Gallia, Jaishri O'Neill Blakeley, Michael K. Lim, Henry Brem, Alfredo Quiñones‐Hinojosa · 2012 · Journal of neurosurgery